Global Molecular Diagnostics Market, 2019 – Research and Markets

DUBLIN, June 16, 2016 /PRNewswire/ —

Research and Markets has announced the addition of the “Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing, Market Size, Strategies and Forecasts 2016-2019 – Global Version” report to their offering.

“Molecular Diagnostics: Infectious Disease, Genetic and Oncology Testing Market Size, Strategies and Forecasts 2016 to 2019 Global Version” provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 Medicare Fee Payment Schedules to help understand test pricing in detail. See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions.

Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges.

Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.

A market that just keeps on growing. Molecular Diagnostics is positioned to directly benefit from the explosion in genomics knowledge. A range of dynamic trends are pushing market growth and company valuations.

– personalized medicine
– pharmacogenomics
– pathogen evolution
– next generation sequencing
– emergence of new economies with large markets
– greater understanding of the role of genetic material in Disease and Health

4. Molecular Diagnostics Recent Developments

– 14M Genomics
– 23andMe
– Agendia
– Agilent/Dako
– All About Truth DNA Services
– Allenex
– AltheaDx
– Amarantus
– Ariosa Diagnostics
– CareDx
– Cepheid
– Firefly BioWorks
– GenomeDx Biosciences
– Genomic Health
– Genomic Vision
– Glyconics
– Good Start Genetics
– Google
– Great Basin Scientific
– Grifols
– Hologic
– HTG Molecular Diagnostics
– Human Longevity
– Illumina
– NanoString
– NEO New Oncology
– Newtopia Garners
– Precipio
– Premaitha
– Protagen
– Roche Molecular Diagnostics
– Rosetta
– Sequenom
– Sequenta
– Sera

For more information visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

SOURCE Research and Markets

Leave a Reply

Your email address will not be published. Required fields are marked *